Homogeneous Emphysema Patients Could Benefit from Zephyr Endobronchial Valve, Study Shows

Emphysema, News

Pulmonx recently announced positive results from the IMPACT (NCT02025205) study assessing the company’s proprietary Zephyr endobronchial valve (EBV), showing that patients with homogeneous emphysema benefit from the treatment. The Zephyr EBV is ... Read more

December 14, 2015December 14, 2015

Advanced Emphysema Patients Respond Well to EBV Therapy in Study

Emphysema, News

Results from the STELVIO trial involving a combination of Zephyr EBV therapy with the Chartis System diagnostic tool revealed significant improvements for patients with severe emphysema. The results were published ... Read more